Effect of Treatment with rhGM-CSF and Low-Dose Cytosine Arabinoside on Leukemic Blast Cells in Patients with Myelodysplastic Syndromes
- 1 January 1990
- book chapter
- Published by Springer Nature
- Vol. 33, 763-769
- https://doi.org/10.1007/978-3-642-74643-7_138
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Recombinant human granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndromes--a phase I/II trialBlood, 1989
- Detection of leukemic clone maturation in vivo by premature chromosome condensationBlood, 1988
- Phase I/II study of recombinant human granulocyte-macrophage colony- stimulating factor in aplastic anemia and myelodysplastic syndromeBlood, 1988
- The pathophysiology and clinical relevance of platelet heterogeneityBlood, 1988
- Effects of Recombinant Human Granulocyte–Macrophage Colony-Stimulating Factor in Patients with Myelodysplastic SyndromesNew England Journal of Medicine, 1987
- Synergism between recombinant growth factors, GM-CSF and G-CSF, acting on the blast cells of acute myeloblastic leukemia [published erratum appears in Blood 1987 Jul;70(1):339]Blood, 1987
- Clonogenic cells in acute myeloblastic leukemiaBlood, 1986
- Effects of recombinant human GM-CSF on proliferation of clonogenic cells in acute myeloblastic leukemiaBlood, 1986
- Recombinant Human Granulocyte Colony-Stimulating Factor: Effects on Normal and Leukemic Myeloid CellsScience, 1986
- Biological activities of a human pluripotent hemopoietic colony stimulating factor on normal and leukemic cells.The Journal of Experimental Medicine, 1985